A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors	Solid Tumor, Adult	Recruiting	Phase 1 / Phase 2	2026-06-25		NCT04219254

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioInvent International AB	5
Merck Sharp & Dohme LLC	650

26 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centrul de Oncologie SF Nectarie SRL	Craiova	Romania	1
Clinica Universidad De Navarra	Pamplona	Spain	20
HealthPartners Institute - Regions Cancer Care Center,	Saint Paul	United States	1
Hm Ciocc Málaga	Málaga	Spain	1
Hospital Puerta de Hierro	Majadahonda	Spain	4
Hospital Universitari Dexeus	Barcelona	Spain	7
Hospital Universitari Vall d´Hebron	Barcelona	Spain	7
Hospital Virgen de la Macarena	Seville	Spain	4
Institut Català d'Oncologia Hospital Duran i Reynals	Barcelona	Spain	1
Institutul Oncologic "Prof. Dr. Ion Chiricuta"	Cluj-Napoca	Romania	2
Instytut Centrum Zdrowia Matki Polki	Lodz	Poland	3
Israel-Georgian Medical Research Clinic Helsicore	Tbilisi	Georgia	1
Jerarsi Clinic	Tbilisi	Georgia	1
Karolinska University Hospital, Solna	Stockholm	Sweden	5
LTD High Technology Hospital Med Center	Batumi	Georgia	2
Lund University Hospital	Lund	Sweden	13
Maria Skłodowska-Curie National Institute of Oncology	Gliwice	Poland	1
Medical University of Silesia	Katowice	Poland	15
Medizinische Hochschule Hannover	Hanover	Germany	42
Nationales Centrum für Tumorerkrankungen	Heidelberg	Germany	1
NEXT Oncology	San Antonio	United States	70
Oklahoma University , Stephenson Cancer Center	Oklahoma City	United States	1
Sahlgrenska University Hospital	Gothenburg	Sweden	96
Sarah Cannon Research Institute	Denver	United States	16
University of California Los Angeles	Los Angeles	United States	10

Clinical trials